Alison L. Hannah

Companies

• RIGEL PHARMACEUTICALS INCEVP, Chief Medical Officer Jul 10, 2026 to now¹
• RIGEL PHARMACEUTICALS INCBoard member May 18, 2021 to now²
• NeoGenomicsBoard member Jun 19, 2015 to now³
• CytomX Therapeutics, Inc.Chief Medical Officer Feb 5, 2020 to Jul 21, 2022⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• NeoGenomics NEO131,023 shares⁵$2.2M at $16.48Jun 1, 2025
• RPRIGEL PHARMACEUTICALS INC RIGL35,025 shares⁶$1.6M at $46.86Jul 8, 2026
• CTCytomX Therapeutics, Inc. CTMX31,898 shares⁷$73.4K at $2.30Jul 20, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 8, 2026Granted 24,400 shares of RIGEL PHARMACEUTICALS INC⁶
• May 15, 2026Granted 5,750 shares of RIGEL PHARMACEUTICALS INC⁸
• Jun 1, 2025Exercised options 12,254 shares of NeoGenomics⁵
• Jun 1, 2025Granted 12,254 shares of NeoGenomics⁹
• May 23, 2025Granted 2,500 shares of RIGEL PHARMACEUTICALS INC¹⁰
• Aug 10, 2024Exercised options 11,336 shares of NeoGenomics¹¹
• May 25, 2024Granted 25,000 shares of RIGEL PHARMACEUTICALS INC¹²
• May 26, 2023Granted 25,000 shares of RIGEL PHARMACEUTICALS INC¹³
• Jul 20, 2022Sold 5,602 shares at $1.42 of CytomX Therapeutics, Inc.⁷
• Jul 19, 2022Granted 15,000 shares of CytomX Therapeutics, Inc.⁷
• Jun 10, 2022Granted 15,556 shares of NeoGenomics¹⁴
• May 20, 2022Granted 25,000 shares of RIGEL PHARMACEUTICALS INC¹⁵
• Feb 2, 2022Granted 22,500 shares of CytomX Therapeutics, Inc.¹⁶